0001209191-17-030238.txt : 20170505 0001209191-17-030238.hdr.sgml : 20170505 20170505132642 ACCESSION NUMBER: 0001209191-17-030238 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170503 FILED AS OF DATE: 20170505 DATE AS OF CHANGE: 20170505 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC CENTRAL INDEX KEY: 0000914475 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330525145 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 617-7600 MAIL ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nevinny Corinne H CENTRAL INDEX KEY: 0001182467 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22705 FILM NUMBER: 17817445 MAIL ADDRESS: STREET 1: C/O EDWARDS LIFESCIENCES CORPORATION STREET 2: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER NAME: FORMER CONFORMED NAME: LYLE CORINNE H DATE OF NAME CHANGE: 20020823 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-03 0 0000914475 NEUROCRINE BIOSCIENCES INC NBIX 0001182467 Nevinny Corinne H 12780 EL CAMINO REAL SAN DIEGO CA 92130 1 0 0 0 Common Stock 2017-05-03 4 M 0 15000 3.40 A 40555 D Common Stock 2017-05-03 4 F 0 952 53.37 D 39603 D Non-Qualified Stock Option 3.40 2017-05-03 4 M 0 15000 0.00 D 2010-06-25 2017-05-25 Common Stock 15000 0 D The share issuance reported on Table I reflects shares issued upon the exercise of options granted on May 25, 2010, which, if unexercised would have expired on May 25, 2017. The option exercises are reported on Table II. These option exercises were pursuant to a net issuance arrangement effected under the issuer's Equity Incentive Plan. The number of shares issued pursuant to the net issuance arrangement was calculated as follows: the option exercise price ($3.40) was subtracted from the May 03, 2017 market close price ($53.57), and this net amount ($50.17) was then multiplied by the number of options (15,000), with the resulting amount then divided by the market close price to result in a net issuance of 14,048 shares to the optionee. The 952 shares underlying the remaining portion of the options are not available for re-issuance, and no shares were sold into the market as a part of the exercise in connection with a net issuance program. /s/ Darin Lippoldt, Attorney-In-Fact 2017-05-05